Event organised by the Westminster Health Forum. Stakeholders and delegates will review the direction of policy under the new government and will discuss next steps for the new life sciences innovative manufacturing fund.
Further areas for discussion include priorities and options for supporting research, innovation and growth in UK life sciences, including long-term investment, reforming regulatory and planning landscapes and improving collaboration between the life sciences sector and the NHS.
Online
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Market Access.
